Cargando…
Signaling crosstalk between RANKL and interferons in osteoclast differentiation
CHAPTER SUMMARY: Regulation of osteoclast differentiation is an aspect central to the understanding of the pathogenesis and the treatment of bone diseases such as autoimmune arthritis and osteoporosis. In fact, excessive signaling by RANKL (receptor activator of nuclear factor κB ligand), a member o...
Autores principales: | Takayanagi, Hiroshi, Kim, Sunhwa, Taniguchi, Tadatsugu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3240156/ https://www.ncbi.nlm.nih.gov/pubmed/12110142 http://dx.doi.org/10.1186/ar581 |
Ejemplares similares
-
Selective Regulation of MAPK Signaling Mediates RANKL-dependent Osteoclast Differentiation
por: Lee, Kyunghee, et al.
Publicado: (2016) -
Fucoidan, a Sulfated Polysaccharide, Inhibits Osteoclast Differentiation and Function by Modulating RANKL Signaling
por: Kim, Young Woo, et al.
Publicado: (2014) -
Magnolol Inhibits Osteoclast Differentiation via Suppression of RANKL Expression
por: Hwang, Youn-Hwan, et al.
Publicado: (2018) -
Roles of Enhancer RNAs in RANKL-induced Osteoclast Differentiation Identified by Genome-wide Cap-analysis of Gene Expression using CRISPR/Cas9
por: Sakaguchi, Yukako, et al.
Publicado: (2018) -
Carboxypeptidase E Is a Novel Modulator of RANKL-Induced Osteoclast Differentiation
por: Kim, Hyun-Ju, et al.
Publicado: (2014)